首页> Alimentary pharmacology & therapeutics> IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.

IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Navneet,Natt

第一单位： Division of Gastroenterology and Hepatology, Department of Medicine, Western University, London, Ontario, Canada.

作者： Navneet,Natt ^[1] ; Monica,Gindi ^[2] ; Gio R,Dela Cruz ^[3] ; Terry,Ponich ^[1] ; James C,Gregor ^[1] ; Nilesh,Chande ^[4] ; Melanie D,Beaton ^[1] ; Keith,McIntosh ^[1] ; Michael,Sey ^[5] ; Reena,Khanna ^[1] ; Richard B,Kim ^[6] ; Aze,Wilson ^[7]

作者单位： Division of Gastroenterology and Hepatology, Department of Medicine, Western University, London, Ontario, Canada. ^[1] Department of Medicine, Western University, London, Ontario, Canada. ^[2] Division of Clinical Pharmacology and Toxicology, Department of Medicine, Western University, London, Ontario, Canada. ^[3] Southwestern Ontario Inflammatory Bowel Disease Clinic, London, Ontario, Canada. ^[4] Division of Gastroenterology and Hepatology, Department of Medicine, Western University, London, Ontario, Canada.;Department of Medicine, Western University, London, Ontario, Canada. ^[5] Division of Clinical Pharmacology and Toxicology, Department of Medicine, Western University, London, Ontario, Canada.;Department of Physiology & Pharmacology, Western University, London, Ontario, Canada. ^[6] Division of Gastroenterology and Hepatology, Department of Medicine, Western University, London, Ontario, Canada.;Division of Clinical Pharmacology and Toxicology, Department of Medicine, Western University, London, Ontario, Canada.;Department of Physiology & Pharmacology, Western University, London, Ontario, Canada. ^[7]

关键词 Crohn's disease inflammatory bowel disease paradoxical psoriasis tumour necrosis factor‐α inhibitors ulcerative colitis